How should I initiate iron supplementation for a patient with serum iron 45 µg/dL, total iron‑binding capacity (TIBC) 232 µg/dL, and transferrin saturation 19.4%?

Iron Supplementation Initiation for Iron Deficiency Without Anemia

Start oral iron supplementation at 100–200 mg elemental iron daily, taken on alternate days on an empty stomach or with 500 mg vitamin C, and reassess iron parameters after 8–10 weeks. 1, 2

Your Patient's Laboratory Interpretation

Your patient has absolute iron deficiency without anemia:

• Transferrin saturation 19.4% is below the 20% threshold, confirming iron-deficient erythropoiesis 1, 2, 3
• TIBC 232 µg/dL is low-normal (reference 250–370 µg/dL), which is unusual but does not exclude iron deficiency 1
• Serum iron 45 µg/dL is low, consistent with depleted iron stores 1

The combination of TSAT <20% with low serum iron defines absolute iron deficiency requiring treatment, even in the absence of anemia. 2, 3

First-Line Treatment: Oral Iron

Dosing Strategy

• Elemental iron dose: 100–200 mg daily in divided doses 1
• Alternate-day dosing (e.g., 100–200 mg every other day) improves absorption and reduces gastrointestinal side effects compared to daily dosing 1, 2
• Common oral formulations include:
  • Ferrous sulfate 325 mg (65 mg elemental iron) 4
  • Ferrous fumarate 325 mg (106 mg elemental iron) 4
  • Polysaccharide iron complex 4

Absorption Enhancement

• Take on an empty stomach or with 500 mg vitamin C to maximize absorption 2
• Avoid taking with calcium or fiber-containing foods, which inhibit absorption 2

Expected Side Effects

• Constipation, diarrhea, and nausea are common (reported in >10% of patients) 1
• Alternate-day dosing significantly reduces these adverse effects 1, 2

Monitoring Response

Timing of Reassessment

• Repeat iron studies after 8–10 weeks of oral iron therapy 1, 2
• Do not recheck earlier, as ferritin levels require this duration to reflect true repletion 1

Expected Laboratory Improvements

• Transferrin saturation should rise to ≥20% 2, 3
• Ferritin should increase to ≥30–45 ng/mL in patients without chronic inflammation 3
• If hemoglobin was low-normal, expect an increase of 1–2 g/dL within 4–8 weeks 3

When to Switch to Intravenous Iron

Consider IV iron if any of the following occur: 1, 2

1. Gastrointestinal intolerance to oral iron (persistent nausea, constipation, or diarrhea preventing adherence)
2. Inadequate response after 8–10 weeks of adequate oral therapy (TSAT remains <20%)
3. Malabsorption conditions (celiac disease, inflammatory bowel disease, prior gastric bypass)
4. Chronic inflammatory conditions develop (chronic kidney disease, heart failure, active IBD, cancer) where hepcidin blocks intestinal iron absorption 1

IV Iron Formulations

• Ferric carboxymaltose 750 mg IV × 2 doses (separated by ≥7 days) for total 1,500 mg per course 5
• Administered over 15 minutes 1, 5
• In critically ill patients with inflammation, a single 1 g dose of ferric carboxymaltose reduced hospital length of stay and 90-day mortality 1

Common Pitfalls to Avoid

• Do not rely on serum iron alone for diagnosis or monitoring—it has high diurnal and day-to-day variability 3
• Do not measure iron parameters within 4 weeks of IV iron infusion—circulating iron falsely elevates ferritin and TSAT 1, 3
• Do not continue oral iron if chronic inflammation develops (e.g., CRP elevated, ferritin rises to 100–300 ng/mL but TSAT remains <20%)—this indicates functional iron deficiency requiring IV iron 1, 3
• Do not supplement iron if ferritin is normal/high without checking TSAT—iron supplementation with normal ferritin is potentially harmful unless TSAT confirms deficiency 1

Target Goals After Repletion

• TSAT ≥20% to ensure adequate iron availability for red cell production 2, 3
• Ferritin ≥30–45 ng/mL in patients without chronic inflammation 3
• Long-term maintenance therapy may be needed if ongoing losses continue (e.g., menstruation, frequent blood donation) 2